KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 151 filers reported holding KEROS THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $193,722 | -57.7% | 4,239 | -38.7% | 0.03% | -53.4% |
| Q1 2024 | $457,839 | +232.8% | 6,916 | +99.9% | 0.06% | +114.8% |
| Q4 2023 | $137,570 | +469.3% | 3,460 | +356.5% | 0.03% | +285.7% |
| Q3 2023 | $24,165 | +55.0% | 758 | +95.4% | 0.01% | +40.0% |
| Q2 2023 | $15,590 | -2.1% | 388 | +4.0% | 0.01% | 0.0% |
| Q1 2023 | $15,927 | +18.5% | 373 | +33.2% | 0.01% | 0.0% |
| Q4 2022 | $13,446 | +49.4% | 280 | +16.2% | 0.01% | +25.0% |
| Q3 2022 | $9,000 | – | 241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 276,000 | $7,626,000 | 3.44% |
| First Light Asset Management, LLC | 598,333 | $16,532,000 | 1.92% |
| Fairmount Funds Management LLC | 272,498 | $7,529,000 | 1.72% |
| Deep Track Capital, LP | 739,528 | $20,433,000 | 1.34% |
| Nantahala Capital Management | 911,901 | $25,196,000 | 1.26% |
| Octagon Capital Advisors LP | 152,249 | $4,207,000 | 1.12% |
| CHI Advisors LLC | 103,429 | $2,858,000 | 1.09% |
| Altium Capital Management LP | 88,000 | $2,431,000 | 0.97% |
| Orbimed Advisors | 1,679,417 | $46,402,000 | 0.84% |
| Parkman Healthcare Partners LLC | 47,788 | $1,320,000 | 0.49% |